Arrowhead Pharmaceuticals
ARWR
Last Price
52 Week Range
$9.57 - $76.76
Next Earnings Date
May 11 2026 (Estimate)
Next Earnings Date
May 11 2026 (Est.)
Last Price
Arrowhead Pharmaceuticals SEC Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Arrowhead Pharmaceuticals, Inc. | 8-K | March 20, 2026 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | February 5, 2026 | |
Arrowhead Pharmaceuticals, Inc. | 10-Q | February 5, 2026 | |
Arrowhead Pharmaceuticals, Inc. | ARS | January 27, 2026 | |
Arrowhead Pharmaceuticals, Inc. | DEFA14A | January 27, 2026 | |
Arrowhead Pharmaceuticals, Inc. | DEF 14A | January 27, 2026 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | January 12, 2026 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | January 9, 2026 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | January 6, 2026 | |
Arrowhead Pharmaceuticals, Inc. | S3ASR | December 11, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 10-K | November 25, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | November 25, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | November 18, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | September 12, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | September 11, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | September 2, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | August 7, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 10-Q | August 7, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 10-Q | May 12, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | May 12, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | April 15, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | March 19, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 10-Q | February 10, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | February 10, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | February 7, 2025 | |
Arrowhead Pharmaceuticals, Inc. | DEFA14A | February 7, 2025 | |
Arrowhead Pharmaceuticals, Inc. | ARS | January 29, 2025 | |
Arrowhead Pharmaceuticals, Inc. | DEFA14A | January 29, 2025 | |
Arrowhead Pharmaceuticals, Inc. | DEF 14A | January 29, 2025 | |
Arrowhead Pharmaceuticals, Inc. | 8-K | December 18, 2024 |
Load More...
Gainify
Features
Platform
Resources
Learn
Socials
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.